Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
Engineering (Ref: ) We now invite applications for the captioned post. Duties and Responsibilities Develop a detailed research plan encompassing data-driven electrolyte screening, molecular dynamics simulations
-
, Lingnan University is transforming into a hub for global leaders to develop and promote human-centric technology and social policies. Further information about Lingnan University is available at https
-
leaders to develop and promote human-centric technology and social policies. Further information about Lingnan University is available at https://www.ln.edu.hk/ . Applications are now invited for
-
-generation cancer immunotherapy - from identification of tumor neoantigens to development of novel therapeutic vaccine modalities”. Qualifications Applicants should have a doctoral degree plus at least six
-
leaders to develop and promote human-centric technology and social policies. Further information about Lingnan University is available at https://www.ln.edu.hk/ . Applications are now invited for
-
leaders to develop and promote human-centric technology and social policies. Further information about Lingnan University is available at https://www.ln.edu.hk/ . Applications are now invited for
-
The University only accepts online application for the above post. Applicants should apply online at the University’s careers site (https://jobs.hku.hk ) and upload an up-to-date C.V., and publications. Review
-
from rich multimodal demonstration data; (b) conduct research on skill composition for complex long-horizon tasks; (c) develop methods for atomic skill retrieval and representation; (d) develop
-
leaders to develop and promote human-centric technology and social policies. Further information about Lingnan University is available at https://www.ln.edu.hk/ . Applications are now invited for
-
Assistant (two posts) [Appointment period: each for twelve months] Duties The appointees will assist the project leader in the research project - “Development of next-generation theranostic agents